Equillium (EQ) Total Current Liabilities (2017 - 2026)
Equillium's (EQ) quarterly Total Current Liabilities came in at $3.3 million in Q1 2026, down 44.27% year-on-year from $6.0 million in Q1 2025, and up 14.01% on a QoQ basis from $2.9 million in Q4 2025.
Equillium (EQ) Total Current Liabilities (2017 - 2026) Analysis & Trends
Equillium (EQ) has 10 years of Total Current Liabilities data on file, last reported at $3.3 million in Q1 2026.
- On a quarterly basis, Total Current Liabilities fell 44.27% year-over-year to $3.3 million in Q1 2026; TTM through Mar 2026 was $3.3 million, a 44.27% decrease from a year earlier, with the FY2025 full-year figure at $2.9 million, down 53.84% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $3.3 million, up from $2.9 million in the prior quarter.
- Over the last five years, Total Current Liabilities for EQ reached as high as $32.0 million in Q4 2022 and fell as low as $2.9 million in Q4 2025.
- Historically, Total Current Liabilities has averaged $15.9 million across 5 years, with a median of $14.9 million in 2022.
- Across the five-year window, Total Current Liabilities jumped 259.37% in 2022 and plunged 76.95% in 2024, its largest moves.
- Year by year, Total Current Liabilities stood at $32.0 million in 2022, then retreated by 13.94% to $27.6 million in 2023, then plunged by 76.95% to $6.4 million in 2024, then plunged by 53.84% to $2.9 million in 2025, then gained by 14.01% to $3.3 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $3.3 million in Q1 2026, $2.9 million in Q4 2025, and $3.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 66.94 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 13.42 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.81 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 289.60 Mn |
| 10 | Equillium | 242.14 Mn | 242.14 Mn | - | 3.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.35 Mn |
| Dec 31, 2025 | 2.93 Mn |
| Sep 30, 2025 | 3.09 Mn |
| Jun 30, 2025 | 7.23 Mn |
| Mar 31, 2025 | 6.00 Mn |
| Dec 31, 2024 | 6.36 Mn |
| Sep 30, 2024 | 11.06 Mn |
| Jun 30, 2024 | 20.17 Mn |
| Mar 31, 2024 | 22.21 Mn |
| Dec 31, 2023 | 27.57 Mn |
| Sep 30, 2023 | 28.20 Mn |
| Jun 30, 2023 | 25.22 Mn |
| Mar 31, 2023 | 32.02 Mn |
| Dec 31, 2022 | 32.04 Mn |
| Sep 30, 2022 | 14.93 Mn |
| Jun 30, 2022 | 15.19 Mn |
| Mar 31, 2022 | 13.11 Mn |
| Dec 31, 2021 | 8.92 Mn |
| Sep 30, 2021 | 7.78 Mn |
| Jun 30, 2021 | 4.98 Mn |